Hollow Fiber Filtration Market to Witness Steady Growth in the Near Future

The growth of this market can be attributed to the rising preference for continuous manufacturing in the biopharmaceutical industry and the increasing demand for biopharmaceuticals across the globe.

The report Hollow Fiber Filtration Market  is projected to reach USD 517.4 million by 2023 from USD 274.7 million in 2018, growing at a CAGR of 13.5%.

Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=267011039

Market Segmentation:-

On the basis of application, the hollow fiber filtration market is segmented into continuous cell perfusion, harvest and clarification, and concentration and diafiltration. In 2018, continuous cell perfusion is expected to be the largest application segment in the hollow fiber filtration market. The biopharmaceutical industry is actively exploring the potential of continuous manufacturing, with a focus on upstream perfusion cell-culture processes that utilize hollow fiber filters. Due to the advantages of hollow fibers, such as achieving efficient cell separation (with low shear) and allowing robust large-scale manufacturing, they are considered as the most suitable form of membrane filters for TFF and ATF perfusion processes.

On the basis of material, the Hollow Fiber Filtration Industry is segmented into polymeric and ceramic materials. In 2018, the polymeric hollow fiber filtration segment is expected to account for a larger share of the market as these filters are widely used in several ultrafiltration and microfiltration applications, including filtration, desalination, and biochemical reactions.

Key Market Drivers: -
            1 Rising Preference for Continuous Manufacturing
            2 Increasing Demand for Biopharmaceuticals

Regional Analysis:-

The Asian Pacific is expected to be the fastest-growing regional market for hollow fiber filtration. The high growth in this regional market can be attributed to the expansion of the biomanufacturing sector, increasing government support, developing R&D infrastructure, and growing outsourcing of bioproduction processes to Asia Pacific countries such as China and India.

Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=267011039  

Top Key Players:-

The Hollow Fiber Filtration Industry is consolidated due to the presence of a few major players. Asahi Kasei Corporation (Japan), Repligen Corporation (US), GE Healthcare (US), Danaher Corporation (US), and Koch Membrane Systems (US) are the leading players in this market.

Blood Screening Market worth $3.5 billion by 2025

The increasing demand for donated blood, the rising number of blood donations, the growing prevalence of infectious diseases, and the increasing prevalence of newer pathogens are the key factors driving the growth of this market.

The Blood Screening Market is projected to reach USD 3.5 billion by 2025 from USD 1.9 billion in 2020, at a CAGR of 12.8%.

Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=267747042

The reagents & kits segment accounted for the largest share of the blood screening market, by product & service, in 2019

Based on product & service, the blood screening market is segmented into reagents and kits, instruments, and software and services. The reagents and kits segment accounted for the largest share of the blood screening market in 2019. The large share of this segment can be attributed to the high consumption and repeated use of reagents & kits in blood screening procedures. Also, the accessibility of a wide range of reagents and the need for reliable, specific, and fast detection of TTIs are driving the growth of the blood screening reagents & kits market.

Blood banks segment to register the highest growth rate during the forecast period

Based on end users, the blood screening market is segmented into blood banks and hospitals. The blood bank segment accounted for the larger market share in 2019 and is projected to witness a higher growth rate during the forecast period. This can be attributed to the increasing demand for donated blood, a growing number of organ transplantation surgeries, rising awareness regarding the safety of blood, an increasing number of donations worldwide, and growth in government funding to charitable trusts.

North America is the largest regional market for blood screening

Based on region, the blood screening market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In 2019, North America accounted for the largest market share, followed by Europe. Factors such as the increasing demand for donated blood, the rising number of blood donations, the growing prevalence of infectious diseases, and the increasing prevalence of newer pathogens, the presence of high-quality infrastructure for hospitals and clinical laboratories, and the presence of major market players in the region are driving the growth of the blood screening market in North America.

Request for Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=267747042  

Top Key Players :-

The prominent players operating in the blood screening market include Grifols (Spain), F. Hoffmann-La Roche AG (Switzerland), Abbott Laboratories (US), BioMérieux (France), Bio-Rad Laboratories (US), Siemens Healthineers (Germany), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US) ,Ortho Clinical Diagnostics, Inc.(US), Becton, Dickinson and Company (US), DiaSorin (Italy), GFE (Germany), Trinity Biotech (Ireland), Merck Millipore (Germany), GE Healthcare (US), Perkin Elmer (US), Bio-Techne Corporation (US), and J Mitra & Co. Pvt. Ltd (India).

Wearable Injectors Market to Progress at a Healthy CAGR in Coming Years

The key factors driving the growth of this market are the growing prevalence of chronic diseases (such as cancer, diabetes, and cardiovascular diseases), favorable reimbursement scenario in major markets, and technological advancements in injector devices.

The Wearable Injectors Market  is projected to reach USD 9.41 billion by 2023 from USD 5.57 billion in 2018, at a CAGR of 11.1% during the forecast period.

Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=100771004

Market Segmentation:-

On the basis of type, the Wearable Injectors Industry is segmented into on-body and off-body injectors. The on-body injectors segment is expected to account for the larger market share in 2018, while the off-body injectors segment is projected to witness the highest growth rate during the forecast period. The drawbacks associated with on-body wearable injectors, such as painful removal, skin sensitivity issues and irritation, and adhesive fitting issues have resulted in the increased adoption of off-body injectors.

On the basis of therapy, the wearable injectors market is segmented into immuno-oncology, diabetes, cardiovascular diseases, and other therapies (Parkinson’s disease, thalassemia, and primary immunodeficiency disorders). In 2018, the immune-oncology segment is expected to account for the largest share of the wearable injectors market. This can be attributed to the high prevalence of cancer across the globe.

Recent Developments:-

• In 2019, Amgen’s Repatha (evolocumab) device options, including the Pre-Filled Syringe and Pushtronex available in the US at a 60% reduced list price.
• In 2018, Amgen received EU approval for Repatha.
• In 2018, Medtronic launched MiniMed670G for diabetic patients
• In 2018, Insulet Corporation (US) partnered with Glooko Inc. (US). According to the partnership, Insulet’s Omnipod System user data will be connected with the Glooko+diasend platform in order to review the blood glucose pattern of patients on smartphones.

Regional Analysis:-

In 2018, North America is expected to account for the largest share of the wearable injectors market, followed by Europe.

Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=100771004

Top Key Players: -

The key players in the global Wearable Injectors Industry are Amgen (US), Medtronic (Ireland), Insulet Corporation (US), Tandem Diabetes Care (US), United Therapeutics Corporation (US), Valeritas (US), and SteadyMed Therapeutics (US). The other prominent players in this market are Ypsomed (Switzerland), Becton, Dickinson and Company (US), Enable Injections (US), Sensile Medicals (Switzerland), and Bespak (UK).

What are the new trends and advancements in the Hemodialysis & Peritoneal Dialysis Market?

Growth in this market is driven by the increasing number of ESRD patients, growing prevalence of diabetes & hypertension, shortage of organ donors and risks associated with transplant, technological advancements and new product launches, and rising R&D expenditure for developing new dialysis products.

The report Hemodialysis & Peritoneal Dialysis Market  is projected to reach USD 99.2 billion by 2024 from USD 74.2 billion in 2019, at a CAGR of 6.0%.

Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1279

Market Segmentation: -

The global hemodialysis market is broadly categorized into two segments, namely, hemodialysis products and hemodialysis services market. The hemodialysis products market include machines (center-use & home-use machines) & consumables (dialyzers, access products, bloodlines, dialysates, and other consumables). The hemodialysis services (including in-center & home- hemodialysis services) segment is expected to account for the largest share of the hemodialysis market.

The peritoneal dialysis market, by modality, includes continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD). The APD segment is expected to grow at the highest CAGR owing to its several advantages over CAPD, such as daytime freedom for patients, fewer connections and disconnections (and hence a lower probability of peritonitis), and improved quality of life. Being automated, APD is also the preferred dialysis treatment for the elderly and children.

Key Market Drivers: –
1 Increasing Number of ESRD Patients
2 Growing Prevalence of Diabetes and Hypertension
3 Shortage of Organ Donors and Risks Associated with Transplant
4 Technological Advancements and New Product Launches
5 Rising R&D Expenditure for Developing New Dialysis Products

Regional Analysis: -

Based on region, the hemodialysis and peritoneal dialysis market has been segmented into four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to account for the largest share of the hemodialysis and peritoneal dialysis market in 2019.

Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=1279

 Key Market Players: -

The major players operating in the global hemodialysis and peritoneal dialysis market are Fresenius Medical Care AG & Co. KGaA (Germany), DaVita Healthcare Partners, Inc. (US), Baxter International, Inc. (US), and B. Braun Melsungen AG (Germany).

 

Clinical Workflow Solutions Market: Trends and Developments

Growth in this market is driven by the implementation of government initiatives supporting the adoption of HCIT solutions, advantages of clinical workflow solutions in enhancing patient care and safety, increasing patient volume due to the COVID-19 pandemic, growing adoption of EHRs and other HCIT solutions, and the rising need to curtail healthcare costs.

The Clinical Workflow Solutions Market  is projected to reach USD 18.1 billion by 2025 from USD 9.1 billion in 2020, at a CAGR of 14.8% during the forecast period.

Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=146901412

Market Segmentation: -

Based on products, the clinical workflow solutions market is segmented into workflow automation solutions, care collaboration solutions, real-time communication solutions, data integration solutions, and enterprise reporting and analytics solutions. The data integration segment is estimated to account for the largest market share in 2019. The large share of this segment can be attributed to the the increasing demand for using medical records and integrating them across hospital departments has been one of the major drivers for data integration solutions.

Based on end users, the clinical workflow solutions market is segmented into hospitals, long-term care facilities, and ambulatory care facilities. The hospital segment is estimated to account for the largest market share in 2019.

Market Drivers:
1 Advantages of clinical workflow solutions in enhancing patient care and safety
2 Government initiatives for HCIT adoption
3 Growing adoption of EHRs and other HCIT solutions
4 Increasing patient volume due to the rising prevalence of chronic diseases and COVID-19
5 Rising need to curtail healthcare costs

Regional Analysis: -

North America is expected to account for the largest share of the clinical workflow solutions market in 2019, followed by Europe. The dominance of the North American region can be attributed to the growing healthcare IT spending, developed infrastructure, evolving regulations for better healthcare outcomes, and the presence of major market players in the region.

Request for Sample Pages: – https://www.marketsandmarkets.com/requestsampleNew.asp?id=146901412

Top Key Players: -

The prominent players in the clinical workflow solutions market are are Hill-Rom Holdings, Inc. (US), Ascom Holding AG (Switzerland), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Cisco Systems, Inc. (US), Stanley Black & Decker, Inc. (US), Cerner Corporation (US), Infor, Inc. (US), Allscripts Healthcare Solutions, Inc. (US), and McKesson Corporation (US).

 

Pharmaceutical Filtration Market: Trends and Developments

Market growth is primarily driven by factors such as growing production of large molecules and biologics, technological advancements in nanofibers, growth in the generics market, and regulatory mandates for cleanrooms in pharmaceutical production. Other factors supporting market growth include an increase in R&D spending by biopharmaceutical companies to offer a strong biologics pipeline.

The global Pharmaceutical Filtration Market is poised to reach USD 22.71 Billion by 2021 from USD 13.73 Billion in 2016, at a CAGR of 10.6% from 2016 to 2021.

Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209343847

The global pharmaceutical filtration market is segmented on the basis of product, technique, application, scale of operation, and region. On the basis of product, the pharmaceutical filtration market is segmented into membrane filters, prefilters and depth media filters, cartridge & capsule filters, single-use systems, filter holders, filtration accessories, and other products. In 2016, the membrane filters segment accounted for the largest share of the market. This segment is also expected to register the highest CAGR during the forecast period. The key factor driving the growth of the membrane filters segment is the ease of installation in large and small manufacturing facilities owing to the availability of a variety of pore and surface types.

Based on application, the final product-processing segment is expected to register the highest CAGR during the forecast period owing to the rapidly growing biologics and generic drug production coupled with the presence of stringent regulatory guidelines to maintain a clean and safe manufacturing environment.

North America accounted for the largest share of the global pharmaceutical filtration market in 2016, followed by Europe. Stringent regulatory guidelines to provide safe drugs is encouraging the use of pharmaceutical filtration products and the presence of a large number of market players are propelling the growth of the North American pharmaceutical filtration market. The Asian region is expected to register the highest CAGR in the forecast period. Growing investments in the biopharmaceutical industry and the rise in contract research and manufacturing organizations in emerging Asian countries are the key factors driving the growth of the Asian market.

Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=209343847  

The pharmaceutical filtration market is dominated by established players such as Merck KGaA (Germany), GE Healthcare (U.S.), Pall Corporation (U.S.), Parker Hannifin Corporation (U.S.), and Sartorius Stedim Biotech S.A. (France).

Laboratory Proficiency Testing Market worth $1103 million by 2024 , at a CAGR of 6.6%

Proficiency testing forms an essential precondition for operational excellence and accreditation in several industries. This is one of the major factors driving the growth of the proficiency testing market, globally. Also, the stringent safety and quality regulations for food and pharmaceutical products and the increasing focus on water testing are the other major factors supporting market growth.

The Laboratory Proficiency Testing Market  is projected to reach USD 1,103 million by 2024 from USD 800 million in 2019, at a CAGR of 6.6% during the forecast period.

Ask for PDF Brochure: -    https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144227949

The cannabis/opioids proficiency testing segment is estimated to grow at the highest CAGR in the laboratory proficiency testing market, by industry, during the forecast period

In the laboratory proficiency testing market, by industry, the cannabis/opioids proficiency testing segment is estimated to grow at the highest CAGR during the forecast period. Growth in this segment is primarily driven by the legalization of medical cannabis, growing number of cannabis testing laboratories, rising awareness about the medical use of cannabis, and the increasing availability of analytical testing instruments and software.

The proficiency testing market for chromatography is estimated to grow at the highest CAGR in the laboratory proficiency testing market, by technology, during the forecast period

In the laboratory proficiency testing market, by technology, the chromatography segment is expected to grow at the highest CAGR during the forecast period. Chromatography is used to carry out complicated separations like amino acid sequencing or pollutant separations, based on differential partitioning between the mobile and stationary phase. The advantages associated with chromatographic testing, such as the increased safety, reliability, and transparency of the pharmaceutical supply chain by testing the identity, strength, purity, quality, and potency of a drug product, and the growth in the pharmaceutical industry as a whole are the major factors driving the growth of this segment.

The Asia Pacific region holds high growth potential in the laboratory proficiency testing market

The Asia Pacific is considered to be the most attractive regional market for laboratory proficiency testing owing to the large base of manufacturers and research laboratories in the region. Also, the growing scientific base and research capabilities in several Asian countries; growth of the Asian pharmaceutical, food, and biologics markets; and the large base of CROs in the region are some of the other major factors driving market growth in the region.

Request for Sample Pages :- https://www.marketsandmarkets.com/requestsampleNew.asp?id=144227949

The prominent players operating in the global laboratory proficiency testing market are LGC Limited (UK), Bio-Rad Laboratories (US), Randox Laboratories (UK), Merck (Germany), College of American Pathologists (US), American Proficiency Institute (US), Waters Corporation (US), QACS (Greece), FAPAS (UK), AOAC (US), Phenova Inc. (US), Weqas (Cardiff), Advanced Analytical Solutions, LLC (UK), Bipea (France), Absolute Standards Inc. (US), and NSI Lab Solutions (US). 

Cone Beam Imaging Market to Progress at a Healthy CAGR in Coming Years

The growth of this market is primarily driven by the factors such as growing prevelance of dental disorders, increasing demand for the cosmetic dentistry and expanding applications of CBCT. In addition to this, new product launches and approvals, partnerships, agreements and collaborations among market players and are also providing impetus for the growth of this market. Moreover, acceptance of the CBCT systems in breast imaging and untapped emerging economies provide significant growth opportunities in the market. However, high cost of the CBCT systems may hinder the growth of this market during the forecast period.

The global CBCT/Cone Beam Imaging Market is expected to reach USD 801.2 Million by 2021 from USD 494.4 Million in 2016, at a CAGR of 10.1% during the forecast period (2016-2021)

Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=226049013

Market Segmentation: -

In this report, the Global CBCT/cone beam imaging market is segmented on the basis of application, patient position, end user and region.

Based on end user, the CBCT/cone beam imaging market is segmented into hospitals, practices and academic and research institutes. The hospital segment is expected to account for the largest share of the CBCT/cone beam imaging market in 2016. However, private practices are expected to grow at highest CAGR during the forecast period.

Growing awareness of dental healthcare, growth in geriatric population (especially in Japan), increasing prevalence of orthopedic disorders, partnerships/collaborations among key players, growing medical tourism for dental services, improving healthcare infrastructure, and growing disposable incomes in emerging Asian economies (such as China and India) are some of the key factors fuelling the growth of this market.

Target Audience:

• Cone beam computed tomography (CBCT) manufacturers and suppliers
• Dental/ENT/orthopedic associations
• Dental imaging equipment manufacturers
• Dental/ENT/orthopedic clinics and hospitals
• Academic institutes and universities
• Medical device manufacturers
• Venture capitalists
• Research and consulting firms

Regional Analysis: -

Based on region, the CBCT/cone beam imaging market is segmented into North America, Europe, Asia and Rest of the World (RoW). In 2016, North America is expected to dominate the market, followed by Europe.

Request for  Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=226049013 

Top key Players: -

Some of key players in this market include Danaher Corporation (U.S.), Carestream Health, Inc. (a subsidiary of Onex Corporation) (Canada), Planmeca Group (Finland), Vatech Co., Ltd. (South Korea), Dentsply Sirona (U.S.), Cefla S.C. (Italy), J. Morita MFG. Corp (Japan), Asahi Roentgen IND.CO., LTD. (Japan), PreXion Corporation (Japan), and CurveBeam LLC (U.S.). New product launches, product approvals, agreements, partnerships, and collaborations were the most-preferred growth strategies adopted by key players between 2013 and 2016

Medical Image Analysis Software Market to Progress at a Healthy CAGR in Coming Years

The increasing advancements in the healthcare solutions and production of innovative solutions by manufacturers in the healthcare industry, the medical image analysis software is projected to record significant growth between 2017 and 2022.

The report Medical Image Analysis Software Market is expected to reach USD 3.9 billion by 2022, registering a CAGR of 8.2%.

Ask for PDF Brochure: – https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=846

Market Segmentation: -

The adoption of smart technology solutions is gradually transforming the approach and treatment procedures practiced in the healthcare industry. To offer cost-effective and quick medical solutions, software developers are focusing on integrating intelligent features such as cloud-based services that provide improved practice management, allow quick access to patient data saved on mobiles & other wearable devices, and monitor quality measures.

As the need for quick access to essential medical information and X-rays for analysis among doctors and surgeons persists, the adoption of integrated software solutions continues to remain high. Integrated software generated the highest revenues in the medical image analysis software market in 2017.

With the increasing number of chronic cases, and the growing number of clinical trial and research studies on medical conditions, the demand for medical analysis software solutions continues to remain high in the healthcare industry. Diagnostic centers, hospitals, and research centers are increasingly adopting these software solutions to maintain patient records and analyze the outcome of various treatment procedures.

Regional Analysis: -

Of the various regions, North America is projected to account for the largest share of the global medical image analysis software market by 2022. A recently published report of the World Health Organization (WHO) stated that by 2020, chronic diseases would account for nearly 73% of all deaths and 60% of the global burden of disease. Moreover, the number of imaging centers is increasing in the region in tandem with the growing geriatric population and the increasing prevalence of various diseases.

Request for  Sample Pages: – https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=846

Top Key Players: -

The increasing presence of new and established players in the medical image analysis software market is likely to intensify the competition. A few prominent market players operating in this market include AQUILAB (France), AGFA Healthcare (Belgium), Esaote S.p.A (Italy), Carestream Health, Inc. (US), and GE Healthcare (US).

Stem Cell Therapy Market: Trends and Developments

Factors such as the growing awareness related to the therapeutic potency of stem cells in disease management, development of advanced genome-based cell analysis techniques, increasing public-private investments for stem cell research, identification of new stem cell lines, and developments in infrastructure for stem cell banking and processing are propelling the growth of the global stem cell therapy market.

The Stem Cell Therapy Market is expected to reach USD 161.8 million by 2022, growing at a CAGR of 11.0% during the forecast period.

Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=48

Market Segmentation: -

On the basis of mode of therapy, the global stem cell therapy market is divided into two major categories, namely, allogeneic stem cell therapy and autologous stem cell therapy. The allogeneic stem cell therapy segment is expected to command the largest share of 95.2% in the global stem cell therapy market in 2017 growing at a CAGR of 11.2% during the forecast period.

On the basis of therapeutic application, the global Stem Cell Therapy Industry is segmented into musculoskeletal disorders, wounds and injuries, cardiovascular diseases, surgeries, gastrointestinal diseases, and other applications. The musculoskeletal disorders segment is expected to command the largest share of 61.1% in the global stem cell therapy market in 2017. Furthermore, the CVS diseases segment is expected to grow at the highest CAGR of 13.0% during the forecast period.

On the basis of cell source, the global Stem Cell Therapy Industry is divided into adipose derived MSCs, bone marrow derived MSCs, embryonic / cord blood SCs, and other cell sources. The adipose derived MSCs segment was expected to account for the largest share of 59.1% in the global stem cell therapy market in 2017.

Market Growth Drivers :-
1 Growing Awareness Related to the Therapeutic Potency of Stem Cells in Effective Disease Management
2 Development of Advanced Genome-Based Cell Analysis Techniques
3 Increasing Public-Private Investments for the Development of Stem Cell Therapies
4 Development in Infrastructure Related to Stem Cell Banking and Processing

Regional Analysis:-

North America is expected to be the largest regional segment in the global stem cell therapy market in 2017, followed by Asia-Pacific. In addition, the North American stem cell therapy market is expected to be the fastest growing region during the forecast period, growing at a CAGR of 11.5%.

Request for Sample Pages  :- https://www.marketsandmarkets.com/requestsampleNew.asp?id=48

Key Market Players:-

As of 2016, Osiris Therapeutics, Inc. (U.S.), MEDIPOST Co., Ltd. (South Korea), Anterogen Co., Ltd. (South Korea), Pharmicell Co., Ltd. (South Korea), Holostem Terapie Avanzate S.r.l. (Italy), JCR Pharmaceuticals Co., Ltd. (Japan), NuVasive, Inc. (U.S.), RTI Surgical, Inc. (U.S.), and AlloSource (U.S.) were some of the key players operating in the global stem cell therapy market.

 

The high growing functionality areas that can be tapped in the Latin America pharmaceutical excipients market.

Growth in this market is driven by the growing pharmaceutical industry in Latin American countries such as Brazil, Mexico, and Argentina; increasing focus of MNCs on investing in the pharmaceutical and healthcare sectors in Latin America; growing pricing pressures; rapid growth in aging population & the subsequent increase in the prevalence of related diseases; and the availability of local and government funding for R&D activities.

The report Latin America Pharmaceutical Excipients Market  is projected to reach USD 579 million by 2024 from USD 403 million in 2019, at a CAGR of 7.5%.

Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=41302221

By functionality, the filler & diluents segment accounted for the largest share of the Latin America pharmaceutical excipients market

The Latin America pharmaceutical excipients market, by functionality, is segmented into fillers & diluents, binders, suspending & viscosity agents, flavoring agents & sweeteners, coating agents, colorants, disintegrants, lubricants & glidants, preservatives, emulsifiers & solubilizers, and other functionalities. The fillers & diluents segment accounted for the largest market share in 2018. The increased use of fillers & diluents in the development and production of solid dosage form and the wide applications of diluents in the wet granulation and direct compression process for tablet formulation are driving the growth of the fillers & diluents segment.

Mexico to dominate the Latin America pharmaceutical excipients market during the forecast period

In 2018, Mexico dominated the Latin America pharmaceutical excipients market, followed by Argentina. Over the past few years, Mexico has become an attractive destination for investment in the pharmaceutical industry due to its large pharmaceutical production and consumption capacity and the improved regulatory framework. Growing pharmaceutical production and consumption, increasing investments by MNCs, and improved regulatory framework are the major factors driving the growth of the pharmaceutical excipients market in Mexico.

Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=41302221

Top key Players: -

Prominent players in the Latin America pharmaceutical excipients market are DowDuPont (US), Roquette (France), Ashland (US), BASF (Germany), and Kerry Group (Ireland).

 

Technology Advancements in Electronic Drug Delivery Systems Market

Factors such as the growing prevalence of target diseases, the favorable reimbursement scenario in major markets, and advancements in technologies & designs of electronic drug delivery systems are driving the growth of the electronic drug delivery systems market during the forecast period. However, emerging economies such as China, India, Russia, and Brazil offer significant growth opportunities for players in the electronic drug delivery market. This can primarily be attributed to the diversified healthcare markets in this region, growing incidence of chronic disorders, and increasing R&D initiatives to develop innovative medical technologies.

The report Electronic Drug Delivery Systems Market is projected to grow at a CAGR of 8.7% during the forecast period to reach USD 11.9 billion by 2024 from USD 7.8 billion in 2019.

Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=165758442

Electronic Wearable Infusion Pumps are expected to be the most widely used type of system in the Electronic Drug Delivery Systems market

The electronic wearable infusion pumps segment accounted for the largest share of the electronic drug delivery systems market in 2018. This is primarily due to the rising prevalence of diabetes and the increasing availability of commercial infusion pumps for diabetes treatment. However, the high cost of electronic drug delivery devices, high acceptance of conventional devices, and lack of reimbursement for electronic drug delivery devices in developing countries could restrain the growth of this segment.

Diabetes segment is expected to account for the largest share of the electronic drug delivery system market by indication

The diabetes segment accounted for the largest share in 2018. This is primarily due to the high prevalence of diabetes across the globe and the greater availability of electronic drug delivery devices, such as insulin pumps and injection pens, for diabetes in comparison to other therapeutic areas. For instance, according to the International Diabetes Federation, in 2017, almost 425 million people were suffering from diabetes worldwide; this is expected to increase to 629 million by 2045.

North America to dominate the electronic drug delivery systems market during the forecast period

In 2018, North America dominated the electronic drug delivery systems market, followed by Europe. High burden of target diseases, favorable reimbursement scenario, and the presence of major market players in this region are the factors propelling the growth of the market. For instance, in April 2018, AstraZeneca (UK) received OTC clearance for its SmartTouch for Symbicort (an electronic inhaler) and launched this product in the US market. Similarly, in December 2017, Companion Medical (US), launched InPen (an electronic injection pen) in the US.

Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=165758442

Top Key Players:-

The prominent players in the electronic drug delivery systems market are Insulet Corporation (US), Bayer AG (Germany), Medtronic (Ireland), Novo Nordisk A/S (Denmark), Companion Medical (US), F.Hoffmann-La Roche Ltd (Switzerland), United Therapeutics Corporation (US), AstraZeneca (UK), Tandem Diabetes Care (US), Merck Group (Germany), and Amgen (US).